Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Eylea. The standard version of the anti-VEGF intravitreal injection delivered $1.4B in net product sales for the company in Q1, indicating a ~29% YoY drop and missing $1.8B projected by analysts ...

Important Safety Information: EYLEA HD and EYLEA are administered via intravitreal injection. Patients should not use EYLEA HD if they have ocular or periocular infections, active intraocular ...

This retrospective case series involved a review of medical records at a single tertiary care center. Charbel Issa and ...

Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) came under pressure in the premarket on Tuesday after the company’s Q1 2025 financials fell short of Street forecasts amid disappointing sales from ...

Diabetic macular edema is a complication that develops from diabetic retinopathy, a widespread consequence of diabetes and a ...

Innovative delivery techniques, including high-tech nanoparticles and electroporationdevices, may convey more gene therapies into the clinic.

But it’s newer versus intravitreal injections ... Between the third and the fourth injection so in EYLEA standard treatment, you do monthly injection or free injection and then you then give ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

EYLEA HD was the only branded medicine in ... administering the product than out of a vial for patients getting intravitreal injections. So, boil all that down, how long can this take?